atorvastatin calcium
- Product NDC
- 68071-2318
- 11-digit product format
- 680712318
- Labeler code
- 68071
- Product ID
- 68071-2318_b69d5d22-4eea-1cfa-e053-2995a90ad1cf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- atorvastatin calcium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA206536
- Marketing category
- ANDA
- Marketing start
- 2018-12-01
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 48A5M73Z4Q | ATORVASTATIN CALCIUM TRIHYDRATE | 344423-98-9 | ATORVASTATIN CALCIUM TRIHYDRATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2318-9 | 68071231809 | 90 TABLET in 1 BOTTLE (68071-2318-9) | 90 tablet | 2020-12-16 | 0000-00-00 | No | No | Current |